I n 2020, the clinical trials industry will continue to focus its attention on value-based outcomes and on getting more real-world evidence. Leaders will develop outcome-driven strategies emphasizing the importance of medications to providers, enabling strong payer partnerships and enhancing patient relationships.

Five key trends that are bound to impact the life sciences industry in the year 2020 are

#1. Driving Better Patient Engagement

A greater attention to patient paves way for meaningful real-world data and better insights into therapy performance and medication adherence. Pharmaceutical companies want to know patients’ response to therapies and identify ideal subpopulations to eventually improve patient outcomes.

• 01. Offer a single view patient portal for maximized engagement and use it as a scalable information center across the entire patient journey. Give your patients frictionless 24/7 multi-device access to disease/drug details, medication training materials, treatment education resources, etc.
• 02. Deliver personalized messages specific to medication or disease state to engage and educate patients, send reminders and check in on progress
• 03. Use AI for predictive analytics to identify patients who will most likely stop following medication and suggest methods of intervention.

#2. Improved Commercial Strategies to Drive Value

Combining data across provider, patient and pharma information on a single platform gives all stakeholders a unified view into actionable customer insights to improve commercial strategies to drive value.

Key aspects to evaluate include:

• 01. Develop a patient-centric Solution to be more collaborative and communicative in your messages and interactions. Give your patients frictionless 24/7 multi-device access to disease/drug details, medication training materials, treatment education resources, etc.
• 02. Transform the care provider relationship to balance the decline in face-to-face relationships. Accelerate transformation through omni channel engagements with payers and providers
• 03. Take advantage of intelligence for intuitive insights into valuable data that helps you create stronger strategies and hyper-personalized, high-touch customer experiences.

#3. Delivering Value Beyond Therapeutics

Services that go over and beyond therapeutics offerings help accelerate revenues, especially with rising concerns of drug patient expirations and biosimilar products making their way into the market.

Clinical research organizations must now deliver value beyond pills while continuing to strengthen patient relationships. Reports suggest that less than half of patients (47%) said pharma companies understood their emotional, financial and other needs related to their condition. Offering value added services and personalized care and support gives the edge for clinical research organizations to win against this perception.

Also, advanced patient engagement strategies and solutions along with therapies help pharmaceutical companies gain that competitive edge: for instance, a mobile app that supports early screening/diagnosis or an app for clinical trials adherence goes a long way in building engagement, loyalty and trust.

#4. Leveraging Artificial Intelligence to Drive Outcomes

Clinical Research Organizations are increasingly leveraging Cloud and AI technologies to increase operational efficiency, deliver actionable insights across R&D and commercial operations.

Structured and standardized data across providers, patients and pharma significantly reduces complexities broadening the horizons for possible innovation. Furthermore, leveraging AI to garner insights from that data fosters accelerated R&D, optimized clinical trials and better outcomes.

Use of AI in clinical trials:

• 01. Predict outcomes and recommend next best actions
• 02. Effortlessly automate workflows
• 03. Predict medication adherence and immediately suggest methods for intervention
• 04. Streamline candidate recruitment for clinical trials
• 05. Offer personalized communications and programs to support patients in navigating their care journey

#5. Delivering Value Beyond Therapeutics

With significant changes driving focus on external innovation, cross-industry and cross- enterprise collaboration is becoming the new norm. To address the future needs of consumers, clinical trial organizations must leverage and scale with a platform that enables frictionless integrations. A 360-degree view into supply chain and manufacturing allows for connected experiences that facilitates cross-team and cross-industry partnerships.